Human D-type cyclin - PubMed (original) (raw)
Comparative Study
. 1991 May 17;65(4):691-9.
doi: 10.1016/0092-8674(91)90100-d.
Affiliations
- PMID: 1827756
- DOI: 10.1016/0092-8674(91)90100-d
Comparative Study
Human D-type cyclin
Y Xiong et al. Cell. 1991.
Abstract
A cDNA library prepared from a human glioblastoma cell line has been introduced into a budding yeast strain that lacks CLN1 and CLN2 and is conditionally deficient for CLN3 function. We rescued a gene that we call cyclin D1. It is related to A-, B-, and CLN-type cyclins, but appears to define a new subclass within the cyclin gene family. Transcription of the cyclin D1 gene gives rise to two major transcripts through alternative polyadenylation. The cyclin D1 gene transcript and its 34 kd product are both abundant in the glioblastoma cell line of origin.
Similar articles
- CLB5: a novel B cyclin from budding yeast with a role in S phase.
Epstein CB, Cross FR. Epstein CB, et al. Genes Dev. 1992 Sep;6(9):1695-706. doi: 10.1101/gad.6.9.1695. Genes Dev. 1992. PMID: 1387626 - Cloning of a D-type cyclin from murine erythroleukemia cells.
Kiyokawa H, Busquets X, Powell CT, Ngo L, Rifkind RA, Marks PA. Kiyokawa H, et al. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2444-7. doi: 10.1073/pnas.89.6.2444. Proc Natl Acad Sci U S A. 1992. PMID: 1372445 Free PMC article. - Comparison of the Saccharomyces cerevisiae G1 cyclins: Cln3 may be an upstream activator of Cln1, Cln2 and other cyclins.
Tyers M, Tokiwa G, Futcher B. Tyers M, et al. EMBO J. 1993 May;12(5):1955-68. doi: 10.1002/j.1460-2075.1993.tb05845.x. EMBO J. 1993. PMID: 8387915 Free PMC article. - Roles and regulation of Cln-Cdc28 kinases at the start of the cell cycle of Saccharomyces cerevisiae.
Dirick L, Böhm T, Nasmyth K. Dirick L, et al. EMBO J. 1995 Oct 2;14(19):4803-13. doi: 10.1002/j.1460-2075.1995.tb00162.x. EMBO J. 1995. PMID: 7588610 Free PMC article. - The CLN gene family: central regulators of cell cycle Start in budding yeast.
Levine K, Tinkelenberg AH, Cross F. Levine K, et al. Prog Cell Cycle Res. 1995;1:101-14. doi: 10.1007/978-1-4615-1809-9_8. Prog Cell Cycle Res. 1995. PMID: 9552356 Review.
Cited by
- From sequencing to validation: NGS-based exploration of plasma miRNA in papillary thyroid carcinoma.
Cui W, Xuan T, Liao T, Wang Y. Cui W, et al. Front Oncol. 2024 Aug 7;14:1410110. doi: 10.3389/fonc.2024.1410110. eCollection 2024. Front Oncol. 2024. PMID: 39169938 Free PMC article. - ZFP36L1 and ZFP36L2 reduce cyclin D1 expression by decreasing expression of E2F1 and long 3'UTR isoform of CCND1 transcripts.
Chan TS, Lee KL, Hung CS, Chiang HP, Chung CC, Liang YC. Chan TS, et al. Mol Cell Biochem. 2024 Aug 7. doi: 10.1007/s11010-024-05087-w. Online ahead of print. Mol Cell Biochem. 2024. PMID: 39110278 - An alternative cell cycle coordinates multiciliated cell differentiation.
Choksi SP, Byrnes LE, Konjikusic MJ, Tsai BWH, Deleon R, Lu Q, Westlake CJ, Reiter JF. Choksi SP, et al. Nature. 2024 Jun;630(8015):214-221. doi: 10.1038/s41586-024-07476-z. Epub 2024 May 29. Nature. 2024. PMID: 38811726 - Long non-coding RNA PVT1 (PVT1) affects the expression of CCND1 and promotes doxorubicin resistance in osteosarcoma cells.
Li Z, Tian JM, Chu Y, Zhu HY, Wang JJ, Huang J. Li Z, et al. J Bone Oncol. 2023 Nov 7;43:100512. doi: 10.1016/j.jbo.2023.100512. eCollection 2023 Dec. J Bone Oncol. 2023. PMID: 38021073 Free PMC article. - A Comprehensive Review of Natural Products as Therapeutic or Chemopreventive Agents against Head and Neck Squamous Cell Carcinoma Cells Using Preclinical Models.
Liew YX, Karen-Ng LP, Vincent-Chong VK. Liew YX, et al. Biomedicines. 2023 Aug 23;11(9):2359. doi: 10.3390/biomedicines11092359. Biomedicines. 2023. PMID: 37760799 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous